McGivney Global Advisors (McGA), a consulting practice for biopharma in oncology, has named Niesha Griffith, MS, RPh as its new advisory partner, it was reported yesterday.

With expertise regarding all aspects of Clinical Pharmacy in Oncology and Cancer Line Services, Griffith has particular expertise across reimbursement, drug contracting and negotiation, drug positioning, formulary management, pharmacy operations and cancer services. In her McGA role, she will provide strategic analyses and direction on innovative payment models, optimal positioning for drug/biologic prescribing, the clinical and economic impact of biosimilars, and a range of other emerging issue areas for McGA clients.

Griffith recently served as vice president, Cancer Services, West Virginia University Health System.

Prior to West Virginia University Health System, Griffith spent 19 years of her career at The Ohio State University Medical Center, with the majority of that time spent at The James Comprehensive Cancer Center. She served in various leadership positions at the James, the last being as the Administrator for Oncology Pharmacy and Infusion Services. She is a past president of the Hematology/Oncology Pharmacy Association, where she previously served as Health Policy chair and board member at large. She is also a fellow of the American Society of Health-System Pharmacists and a member of the Advisory Board of the Institute for Clinical Immuno-Oncology of the ACCC.